- Open Access
It’s not just the antibiotics, it’s the treatment
Critical Care volume 18, Article number: 147 (2014)
The recent study by Bloos and colleagues demonstrates that early initiation of antimicrobial therapy is not associated with improved survival in sepsis. We contend that these findings should not be surprising. This study is yet another part of the growing case against early and aggressive antimicrobial therapy and highlights the important roles resuscitation and source control play in the management of the septic patient. We suggest that, whenever possible, antimicrobial therapy should we withheld until objective evidence of infection has been obtained.
Bloos and colleagues  present the results of a large, prospective, multicenter, cohort study of patients in severe sepsis or septic shock. The authors evaluated 1,011 medical and surgical patients. They identified that, in all cases, delay of antimicrobial therapy of more than 1 hour was not independently associated with mortality. In the surgical cohort, a delay in source control greater than 6 hours was significantly associated with mortality. For the combined cohort, inappropriate therapy was also associated with mortality on multivariate analysis. These results are compelling and go against conventional wisdom on this subject.
In studies of this type it is often difficult to discern the true time of infection. This study is no different. The authors have chosen to use the time of first infection-related organ dysfunction. While we appreciate its objective nature, this definition presents a two-fold problem. Firstly, 57.4 % of patients developed sepsis in the ICU. Presumably, most ICU patients were there in the first place because of some underlying organ dysfunction. It may not be immediately apparent that this dysfunction is infection-related, making this a definition that can only be applied retrospectively. For example, how did the authors handle ventilator-associated pneumonia, where patients by definition already had failure of one organ system? Secondly, 13.9% of patients 'developed' sepsis in the emergency department. Therefore, the time until initiation of therapy is more indicative of the time from arrival until recognition of sepsis than the true time from onset of organ dysfunction. These patients were likely suffering organ dysfunction upon arrival to the emergency department. It would be interesting to see the results with these patients excluded.
Should these findings have been surprising? We think not. The author’s cite a meta-analysis by Barochia and colleagues  that suggests that timely administration of antimicrobials is associated with improved survival. However, this finding was only significant after removing the effects from Rivers and colleagues’ study on early goal-directed therapy . Another meta-analysis conducted on studies of outpatient respiratory infections found no difference between immediate or delayed antibiotic therapy . Puskarich and colleagues  demonstrated that, in the setting of appropriate resuscitation, the timing of antimicrobial therapy appears to have little effect on mortality. Similarly, Hranjec and colleagues  found that, assuming resuscitation and source control occur in a timely manner, intentionally withholding antimicrobial therapy until infection can be objectively proven to result in improved patient outcomes compared with early and aggressive initiation. These studies focused on emergency department and ICU management, respectively. Bloos and colleagues’ study confirms the findings of Hranjec and colleagues and Puskarich and colleagues, while spanning the entire spectrum of hospitalization.
This trial also suffers from the most common deficit in most studies of timing of antimicrobial therapy in patients with severe sepsis or septic shock: the lack of a proper control group. The question faced by the clinician is not whether a patient with proven infection should have the rapid initiation of antimicrobials, but whether a patient who might be infected should receive therapy. Missing in this study is the group of patients who received antimicrobials for suspected infection but were not infected, and what the consequences of this unnecessary exposure to antibiotics were. However, the data are reassuring to us who believe that it is prudent to wait until there is objective microbiological data to support the diagnosis of infection before initiating therapy. Even among these patients with significant disease, the exact timing of antimicrobial therapy did not appear to be the main driver of outcomes.
At its core, the narrow-focused debate surrounding the timing of antimicrobial therapy is inherently flawed. The appropriate treatment of the septic patient requires a rapid multimodal response including fluid resuscitation, source control, and pressors (if required). Antimicrobials are only one part of this equation. In cases of life threatening septic shock, broad-spectrum empiric therapy should be initiated as soon as possible. However, the harmful effects of inappropriate antimicrobials should be mitigated, whenever possible, by using culture-guided therapy and delayed initiation. In all cases, resuscitation and source control should be the highest priority. Bloos and colleagues’ study is a reminder that antimicrobials, while important, are not the only tools in our arsenal against infectious disease.
Overall, Bloos and colleagues have provided another interesting wrinkle in the story of antimicrobials and sepsis. Their study is well executed and practical, and the authors are to be commended for their excellent work. We look forward to the results of their randomized trial.
Bloos F, Thomas-Ruddel D, Ruddel H, Engel C, Schwarzkopf D, Marshall JC, Harbarth S, Simon P, Riessen R, Keh D, Dey K, Weiss M, Toussaint S, Schadler D, Weyland A, Ragaller M, Schwarzkopf K, Eiche J, Kuhnle G, Hoyer H, Hartog C, Kaisers U, Reinhart K: Impact of compliance with infection management guidelines on outcome in patients with severe sepsis: a prospective observational multi-center study. Crit Care 2014, 18: R42. 10.1186/cc13755
Barochia AV, Cui X, Vitberg D, Suffredini AF, O'Grady NP, Banks SM, Minneci P, Kern SJ, Danner RL, Natanson C, Eichacker PQ: Bundled care for septic shock: an analysis of clinical trials. Crit Care Med 2010, 38: 668-678. 10.1097/CCM.0b013e3181cb0ddf
Rivers E, Nguyen B, Havstad S, Ressler J, Muzzin A, Knoblich B, Peterson E, Tomlanovich M: Early goal-directed therapy in the treatment of severe sepsis and septic shock. N Engl J Med 2001, 345: 1368-1377. 10.1056/NEJMoa010307
Spurling GK, Del Mar CB, Dooley L, Foxlee R, Farley R: Delayed antibiotics for respiratory infections. Cochrane Database Systematic Rev 2013., 4: CD004417
Puskarich MA, Trzeciak S, Shapiro NI, Arnold RC, Horton JM, Studnek JR, Kline JA, Jones AE: Association between timing of antibiotic administration and mortality from septic shock in patients treated with a quantitative resuscitation protocol. Crit Care Med 2011, 39: 2066-2071. 10.1097/CCM.0b013e31821e87ab
Hranjec T, Rosenberger LH, Swenson B, Metzger R, Flohr TR, Politano AD, Riccio LM, Popovsky KA, Sawyer RG: Aggressive versus conservative initiation of antimicrobial treatment in critically ill surgical patients with suspected intensive-care-unit-acquired infection: a quasi-experimental, before and after observational cohort study. Lancet Infect Dis 2012, 12: 774-780. 10.1016/S1473-3099(12)70151-2
The authors declare that they have no competing interests.
Both authors drafted, made critical revisions, read, and approved this manuscript.
About this article
Cite this article
Guidry, C.A., Sawyer, R.G. It’s not just the antibiotics, it’s the treatment. Crit Care 18, 147 (2014) doi:10.1186/cc13904
- Septic Shock
- Severe Sepsis
- Organ Dysfunction
- Antimicrobial Therapy
- Septic Patient